ETF Holdings Breakdown of IBRX

Stock NameImmunitybio Inc
TickerIBRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45256X1037
LEI529900J9XLBR4HFL4B83

News associated with IBRX

Piper Sandler Upgrades ImmunityBio (NASDAQ:IBRX) to Overweight
ImmunityBio (NASDAQ:IBRX – Get Free Report) was upgraded by investment analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a note issued to investors on Tuesday, Marketbeat.com reports. The firm currently has a $5.00 price target on the stock, up from their previous price target of $4.25. Piper Sandler’s price objective […] - 2025-05-22 05:44:47
ImmunityBio (NASDAQ:IBRX) Given Buy Rating at HC Wainwright
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $8.00 target price on the stock. HC Wainwright’s price objective suggests a potential upside of 218.73% from the stock’s current price. Separately, D. Boral Capital reissued […] - 2025-05-14 08:04:48
D. Boral Capital Reiterates “Buy” Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a note issued to investors on Monday,Benzinga reports. They currently have a $30.00 price objective on the stock. Separately, HC Wainwright reaffirmed a “buy” rating on shares of ImmunityBio in a research note on Monday, May […] - 2025-05-14 08:04:48
ImmunityBio, Inc. (NASDAQ:IBRX) Stake Reduced by Legal & General Group Plc
Legal & General Group Plc lessened its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 7.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 131,364 shares of the company’s stock after selling 11,161 shares during the quarter. Legal & General Group Plc’s holdings in ImmunityBio were worth $336,000 at […] - 2025-05-01 08:24:53
Geode Capital Management LLC Decreases Stock Holdings in ImmunityBio, Inc. (NASDAQ:IBRX)
Geode Capital Management LLC cut its stake in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 0.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,840,918 shares of the company’s stock after selling 5,757 shares during the period. Geode Capital Management LLC’s holdings […] - 2025-04-24 07:58:48
LPL Financial LLC Raises Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)
LPL Financial LLC grew its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 67.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,449 shares of the company’s stock after buying an additional 103,495 shares during the period. LPL […] - 2025-04-24 07:10:54
Teacher Retirement System of Texas Has $107,000 Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)
Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,742 shares of the company’s stock after acquiring an additional 7,067 shares during the period. […] - 2025-04-03 07:54:52
Comparing ImmunityBio (NASDAQ:IBRX) & Curis (NASDAQ:CRIS)
ImmunityBio (NASDAQ:IBRX – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and […] - 2025-04-02 05:20:51
Stephens Inc. AR Invests $26,000 in ImmunityBio, Inc. (NASDAQ:IBRX)
Stephens Inc. AR acquired a new position in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,090 shares of the company’s stock, valued at approximately $26,000. Several other large […] - 2025-02-18 08:16:55
After Hours Most Active for Jan 27, 2025 : VTWO, NVDA, AAPL, T, QQQ, IBRX, GOOGL, BAC, AA, GAP, BABA, XOM
The NASDAQ 100 After Hours Indicator is up 67.15 to 21,194.43. The total After hours volume is currently 157,887,661 shares traded.The following are the most active stocks for the after hours session: Vanguard Russell 2000 ETF (VTWO) is +0.1 at $91.72, with 9,652,088 shares trad - 2025-01-27 21:24:58

IBRX institutional holdings

The following institutional investment holdings of IBRX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-07-02 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 200,843USD 530,226
2025-07-02 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 26,512USD 69,992
2025-07-02 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 288,177USD 760,787
2025-07-02 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 523,893USD 1,383,078
2025-07-02 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 523,893USD 1,383,078
Total =1,563,318 USD 4,127,161
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.